| Geographic distribution of the 20210 G to A prothrombin variant FR Rosendaal, CJM Doggen, A Zivelin, VR Arruda, M Aiach, DS Siscovick, ... Thrombosis and haemostasis 79 (04), 706-708, 1998 | 1000 | 1998 |
| Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism J Emmerich, FR Rosendaal, M Cattaneo, M Margaglione, V De Stefano, ... Thrombosis and haemostasis 86 (09), 809-816, 2001 | 540 | 2001 |
| Prevalence of antithrombin deficiency in the healthy population RC Tait, ID Walker, DJ Perry, S Islam, ME Daly, F McCall, JA Conkie, ... British journal of haematology 87 (1), 106-112, 1994 | 535 | 1994 |
| Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia M Makris, FE Preston, NJ Beauchamp, PC Cooper, ME Daly, KK Hampton, ... Thrombosis and haemostasis 78 (12), 1426-1429, 1997 | 234 | 1997 |
| High prevalence of a mutation in the factor V gene within the UK population: relationship to activated protein C resistance and familial thrombosis NJ Beauchamp, ME Daly, KK Hampton, PC Cooper, FE Preston, IR Peake British journal of haematology 88 (1), 219-222, 1994 | 198 | 1994 |
| Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S M Makris, M Leach, NJ Beauchamp, ME Daly, PC Cooper, KK Hampton, ... Blood, The Journal of the American Society of Hematology 95 (6), 1935-1941, 2000 | 182 | 2000 |
| Determinants of platelet count in humans ME Daly Haematologica 96 (1), 10, 2011 | 166 | 2011 |
| Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism M Margaglione, G D’Andrea, D Colaizzo, G Cappucci, A del Popolo, ... Thrombosis and haemostasis 82 (12), 1583-1587, 1999 | 165 | 1999 |
| Novel platelet membrane glycoprotein VI dimorphism is a risk factor for myocardial infarction SA Croft, NJ Samani, MD Teare, KK Hampton, RP Steeds, KS Channer, ... Circulation 104 (13), 1459-1463, 2001 | 152 | 2001 |
| Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects B Johnson, GC Lowe, J Futterer, M Lordkipanidzé, D MacDonald, ... haematologica 101 (10), 1170, 2016 | 138 | 2016 |
| Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test J Curvers, MCLGD Thomassen, J Rimmer, K Hamulyak, J van der Meer, ... Thrombosis and haemostasis 88 (07), 5-11, 2002 | 132 | 2002 |
| Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment? ME Daly, A Makris, M Reed, CE Lewis Journal of the National cancer Institute 95 (22), 1660-1673, 2003 | 130 | 2003 |
| Evaluation of participants with suspected heritable platelet function disorders including recommendation and validation of a streamlined agonist panel BB Dawood, GC Lowe, M Lordkipanidzé, D Bem, ME Daly, M Makris, ... Blood, The Journal of the American Society of Hematology 120 (25), 5041-5049, 2012 | 128 | 2012 |
| Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects J Stockley, NV Morgan, D Bem, GC Lowe, M Lordkipanidzé, B Dawood, ... Blood, The Journal of the American Society of Hematology 122 (25), 4090-4093, 2013 | 127 | 2013 |
| Antithrombins Wibble and Wobble (T85M/K): archetypal conformational diseases with in vivo latent-transition, thrombosis, and heparin activation NJ Beauchamp, RN Pike, M Daly, L Butler, M Makris, TR Dafforn, A Zhou, ... Blood, The Journal of the American Society of Hematology 92 (8), 2696-2706, 1998 | 126 | 1998 |
| Common sequence variations in the P2Y12 and CYP3A5 genes do not explain the variability in the inhibitory effects of clopidogrel therapy SMG Smith, HM Judge, G Peters, M Armstrong, P Fontana, P Gaussem, ... Platelets 17 (4), 250-258, 2006 | 110 | 2006 |
| The GPIa C807T dimorphism associated with platelet collagen receptor density is not a risk factor for myocardial infarction SA Croft, KK Hampton, JA Sorrell, RP Steeds, KS Channer, NJ Samani, ... British journal of haematology 106 (3), 771-776, 1999 | 104 | 1999 |
| A novel von Willebrand disease–causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion S Allen, AM Abuzenadah, J Hinks, JL Blagg, T Gursel, J Ingerslev, ... Blood, The Journal of the American Society of Hematology 96 (2), 560-568, 2000 | 93 | 2000 |
| Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease–causing variants of von Willebrand factor G Michaux, LJ Hewlett, SL Messenger, AC Goodeve, IR Peake, ME Daly, ... Blood 102 (7), 2452-2458, 2003 | 92 | 2003 |
| Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PlA2) is a risk factor for bypass occlusion, myocardial infarction, and death RB Zotz, M Klein, HP Dauben, C Moser, E Gams, RE Scharf Thrombosis and haemostasis 83 (03), 404-407, 2000 | 92 | 2000 |
